ROIVRoivant Sciences Ltd. Common Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 21093
Ticker: ROIV
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-10-01
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ROIV

Detail

Enriched 2026-08-14 20:47

Market cap: $26,119,200,222.4
Shares outstanding (class): 722,323,015
Shares outstanding (weighted): 722,323,015
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 721
Location: LONDON
Homepage: https://www.roivant.com
Description: Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Market cap and share counts drift.

Funds holding this security

191 funds · 194 positions · $3.02B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Mid-Cap ETF iShares Trust	IJH	$413.52M	0.39%	14,928,457 NS	TICKER
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$409.75M	0.02%	14,792,282 NS	TICKER
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$297.13M	0.18%	10,726,708 NS	TICKER
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$166.23M	0.43%	6,001,140 NS	TICKER
GROWTH PORTFOLIO MORGAN STANLEY INSTITUTIONAL FUND INC	—	$151.31M	4.60%	5,462,307 NS	TICKER
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$139.42M	0.17%	5,033,134 NS	TICKER
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$123.20M	1.13%	4,447,673 NS	TICKER
Morgan Stanley Discovery Portfolio Brighthouse Funds Trust I	—	$105.68M	9.44%	3,815,124 NS	TICKER
iShares Biotechnology ETF iShares Trust	IBB	$100.90M	1.24%	3,642,557 NS	TICKER
State Street SPDR S&P MidCap 400SM ETF Trust —	—	$94.14M	0.39%	3,398,422 NS	TICKER
Fidelity Contrafund Fidelity Contrafund	—	$93.98M	0.06%	3,392,647 NS	TICKER
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$79.34M	1.07%	2,864,237 NS	TICKER
Discovery Portfolio MORGAN STANLEY INSTITUTIONAL FUND TRUST	—	$73.71M	9.92%	2,660,961 NS	TICKER
State Street(R) SPDR(R) Portfolio S&P 400(TM) M… SPDR SERIES TRUST	SPMD	$61.01M	0.39%	2,202,653 NS	TICKER
Morgan Stanley Insight Fund Morgan Stanley Insight Fund	—	$53.37M	4.77%	1,926,750 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERROIV
CIK0001635088
ISINBMG762791017
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Roivant Sciences is a biopharmaceutical company focused on drug development, classified under pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.